What is Amphetamine-Dextroamphetamine?
Category: Prescription Drugs
Most popular types: Adderall Adderall XR Amphetamine Salts Show all
See also: Dextroamphetamine
The combination of dextroamphetamine and amphetamine is in a class of medications called central nervous system stimulants. It is used as part of a treatment program for attention deficit hyperactivity disorder (ADHD). Also used to treat narcolepsy, a sleep disorder causing sudden sleep attacks.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Attention deficit/hyperactivity disorder | 1812 | 661 | |
| Fatigue | 796 | 493 | |
| Problems concentrating | 560 | 373 | |
| Attention deficit disorder | 146 | 81 | |
| Excessive daytime sleepiness (somnolence) | 95 | 81 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 82 | |
| Moderate | 246 | |
| Mild | 496 | |
| None | 529 |
Commonly reported side effects and conditions associated with Amphetamine-Dextroamphetamine
| Side effect | Patients | Percentage |
|---|---|---|
| Decreased appetite | 103 | |
| Dry mouth | 85 | |
| Weight loss | 49 | |
| Anxious mood | 48 | |
| Insomnia | 48 | |
| Headaches | 40 |
Why patients stopped taking Amphetamine-Dextroamphetamine
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Side effects too severe | 167 | |
| Did not seem to work | 162 | |
| Doctor's advice | 134 | |
| Other | 133 | |
| Expense | 41 | |
| Personal research | 37 | |
| Change in health plan coverage | 30 | |
| Course of treatment ended | 20 |
Duration
Stopped taking Amphetamine-Dextroamphetamine
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 89 | |
| 1 - 6 months | 113 | |
| 6 months - 1 year | 74 | |
| 1 - 2 years | 64 | |
| 2 - 5 years | 101 | |
| 5 - 10 years | 49 | |
| 10 years or more | 27 |
What people switch to and from
Patients started taking Amphetamine-Dextroamphetamine after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Methylphenidate (Ritalin) | 95 | |
| Lisdexamfetamine (Vyvanse) | 54 | |
| Modafinil (Provigil) | 46 | |
| Atomoxetine (Strattera) | 22 | |
| Amphetamine-Dextroamphetamine (Adderall) | 20 |
Patients stopped taking Amphetamine-Dextroamphetamine and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Lisdexamfetamine (Vyvanse) | 67 | |
| Methylphenidate (Ritalin) | 37 | |
| Amphetamine-Dextroamphetamine (Adderall) | 20 | |
| Modafinil (Provigil) | 18 | |
| Dextroamphetamine (Dexedrine) | 11 |
Last updated: